Reproductive Embryo Editing: Attending to Justice
By Inmaculada De Melo-Martín,
The Hastings Center Report
| 08. 22. 2022
Advances in genome editing technologies allow scientists to add, remove, or alter genetic material at particular locations in the human genome. Genome editing of somatic cells offers great promise in the prevention and treatment of various human diseases. But these technologies could also be used to modify gametes and embryos. Some commentators defend gene editing for reproductive purposes on the ground that it would allow people who are at risk of transmitting genetic diseases to their offspring to have healthy and genetically related children.
Using gene editing in this way would require further research. The technology still presents problems involving off-target effects and reliability. Researchers must improve delivery to desired tissues and control of immunogenic reactions. Yet I argue here that, if we accept certain background claims about justice, accepting the goal of helping people have healthy and genetically related children should commit one to rejecting the investment of social resources into further development of reproductive embryo editing.
Considerations of justice are relevant to questions regarding the development of reproductive embryo editing for several reasons. First, decisions about research-funding priorities involve...
Related Articles
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...